BlackJack3D/E+ via Getty Images
Twist Bioscience (NASDAQ:TWST) and Ginkgo Bioworks (NYSE:DNA) said on Thursday that they have updated a previous agreement signed in 2022.
Under the new three-year $15M deal, Ginkgo will remain a customer of Twist, making annual prepayments for Twist’s DNA products.
